Showing results (181-190 of 912) with videos related to

Sort By:
Pageof 92
Annals of General Psychiatry|December 28, 2024
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled studyLuigi Giuliani, Pasquale Pezzella, Armida Mucci, et al.
Annals of General Psychiatry|January 28, 2025
Mental health literacy among primary care providers in Hungary: a vignette-based surveyValerie S Swisher, Dorottya Őri, Zoltán Rihmer, et al.
Annals of General Psychiatry|February 18, 2025
Salivary hormones in depression: the future in diagnosis and treatmentStefan Harsanyi, Ida Kupcova, Maria Csobonyeiova, et al.
Annals of General Psychiatry|January 13, 2025
Expression study of Wnt/β-catenin signaling pathway associated lncRNAs in schizophreniaFatemeh Manafzadeh, Behzad Baradaran, Seyed Gholamreza Noor Azar, et al.
Annals of General Psychiatry|August 27, 2024
Association between rTMS-induced changes in inflammatory markers and improvement in psychiatric diseases: a systematic reviewBruno Pedraz-Petrozzi, Shrabon Insan, Moritz Spangemacher, et al.
Annals of General Psychiatry|August 2, 2024
Predictors of continuation for asenapine from real-world data in patients with schizophreniaYoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, et al.
Annals of General Psychiatry|August 2, 2024
Global, regional, and national time trends in incidence for depressive disorders, from 1990 to 2019: an age-period-cohort analysis for the GBD 2019Yuhang Wu, Luying Fan, Fan Xia, et al.
Annals of General Psychiatry|June 26, 2024
Empowerment of Italian general practitioners in depression and suicide prevention: the iFightDepression tool, a game changer of the EAAD-Best projectNuhara Vargiu, Aurora Belfanti, Michela Roberti, et al.
Annals of General Psychiatry|July 22, 2024
Brain-derived neurotrophic factor and C-reactive protein (CRP) biomarkers in suicide attempter and non-attempter major depression disorder (MDD) patientsSeyed Hassan Saadat, Mohammad Javanbakht, Shima Shahyad
Annals of General Psychiatry|November 14, 2023
A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)Ping Guo, Yong Xu, Liang Lv, et al.
Pageof 92